NCT03170947

Brief Summary

Deformity and foot pain is nearly omnipresent (90%) in rheumatoid arthritis (RA), due to the interaction between inflammation and abnormal biomechanical. These cause instability in the hindfoot, which cause deformity of the forefoot, and they cause more pressure on the plantar forefoot and more pain during daily activities. Non-pharmacological interventions (insole, footwear) have an important role, reducing pain and disability, increasing the effectiveness and improving daily activities.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
96

participants targeted

Target at P50-P75 for not_applicable rheumatoid-arthritis

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable rheumatoid-arthritis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 31, 2017

Completed
4.6 years until next milestone

Study Start

First participant enrolled

January 21, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

January 18, 2023

Status Verified

January 1, 2023

Enrollment Period

2.9 years

First QC Date

May 26, 2017

Last Update Submit

January 16, 2023

Conditions

Keywords

Rheumatoid arthritisFootInsolesQuality of lifePhysical Activity

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline Active graph (bracelet) at 3 months

    This outcome will be measured with an activity monitor, accelerometer

    one week, one month and three months

Secondary Outcomes (4)

  • Change from Baseline quality of life at 3 months

    one week, one month and three months

  • Change from Baseline foot function 3 months

    one week, one month and three months

  • Change from Baseline pain intensity at 3 months

    one week, one month and three months

  • Change from Baseline physical activity at 3 months

    one week, one month and three months

Study Arms (2)

Custom insoles

EXPERIMENTAL

Custom insoles will make with CAD-CAM using a laser scanning and casting for its construction. Custom insoles will make with direct adaptation technique (TAD) being of pvc resin.

Device: Custom Insoles

Standardized insoles

ACTIVE COMPARATOR

Standardized insoles will be done by Ethylene-vinyl acetate (EVA) material.

Device: Standardized insoles

Interventions

Custom insoles will make with CAD-CAM using a laser scanning and casting for its construction. All this needs the assistance of a computer. From the digital image of a positive of the limb in foam the insole will be obtained. Custom insoles make with direct adaptation technique (TAD) being of pvc resin. Once the resins are cut and with a temperature of 90º, they will be adapted to the foot (which will be protected with a sock) of the patient with the help of a vacuum. To this technique subtalar joint will be in a neutral position and metatarsal joints will be aligned.

Custom insoles

Standardized insoles were done by EVA material with shore of 18 and 180 kg/cm3 and manufactured, with an extension of 3/4. It was in contact with heel and plantar arch.

Standardized insoles

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • More than 18 years of age
  • Early RA
  • To meet the criteria of American College of Rheumatology
  • History of bilateral subtalar and/or ankle and/or talonavicular pain
  • Informed consent
  • Normal range of motions at the ankle, subtalar, and midtarsal joints.

You may not qualify if:

  • Concomitant musculoskeletal disease
  • Central or peripheral nervous system disease
  • Endocrine disorders, especially diabetes mellitus with a level of insufficient foot sensitivity
  • Patients with a history of orthopedic foot surgery
  • Those currently using foot orthoses.
  • Patients with foot trauma in the last 6 months previous to the study
  • Vascular diseases affecting the foot, active synovitis and edema.
  • Normal daily walking aids will be not permitted.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Malaga

Málaga, 29071, Spain

RECRUITING

Related Publications (2)

  • Ramos-Petersen L, Nester CJ, Ortega-Avila AB, Skidmore S, Gijon-Nogueron G. A qualitative study exploring the experiences and perceptions of patients with rheumatoid arthritis before and after wearing foot orthoses for 6 months. Health Soc Care Community. 2021 May;29(3):829-836. doi: 10.1111/hsc.13316. Epub 2021 Feb 9.

  • Ramos-Petersen L, Nester CJ, Gijon-Nogueron G, Ortega-Avila AB. Foot orthoses for people with rheumatoid arthritis, involving quantitative and qualitative outcomes: protocol for a randomised controlled trial. BMJ Open. 2020 Jul 19;10(7):e036433. doi: 10.1136/bmjopen-2019-036433.

MeSH Terms

Conditions

Arthritis, RheumatoidMotor Activity

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Study Officials

  • Gabriel Gijon Nogueron, PhD

    University of Malaga

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Laura Ramos Petersen, Podiatry

CONTACT

Gabriel Gijon Nogueron, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 26, 2017

First Posted

May 31, 2017

Study Start

January 21, 2022

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

January 18, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations